RHYTHM PHARMACEUTICALS, INC. — Director's Dealing 2017

Oct 4, 2017

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: RHYTHM PHARMACEUTICALS, INC. (RYTM)
CIK: 0001649904
Period of Report: 2017-10-04

Reporting Person: Desikan Nithya (Chief Commercial Officer)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Employee Stock Option (Right to Buy)	$6.88	2027-08-08	Common Stock (201744)		Direct

Footnotes

F1: The stock options were granted on August 9, 2017. 32,715 of the total shares vested and became exercisable immediately upon grant. The remaining stock options vest and become exercisable as to 25% of the total remaining shares on July 23, 2018 and, thereafter, in 36 successive, equal monthly installments.